An inhibitor's-eye view of the ATP-binding site of CDKs in different regulatory states.
about
Targeting cyclin-dependent kinases in human cancers: from small molecules to Peptide inhibitorsRecent progress of cyclin-dependent kinase inhibitors as potential anticancer agents.Discovery of 4,6-disubstituted pyrimidines as potent inhibitors of the heat shock factor 1 (HSF1) stress pathway and CDK9.Ensemble-based modeling and rigidity decomposition of allosteric interaction networks and communication pathways in cyclin-dependent kinases: Differentiating kinase clients of the Hsp90-Cdc37 chaperone.Network-based modelling and percolation analysis of conformational dynamics and activation in the CDK2 and CDK4 proteins: dynamic and energetic polarization of the kinase lobes may determine divergence of the regulatory mechanisms.CDK5 in oncology: recent advances and future prospects.
P2860
An inhibitor's-eye view of the ATP-binding site of CDKs in different regulatory states.
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
An inhibitor's-eye view of the ATP-binding site of CDKs in different regulatory states.
@ast
An inhibitor's-eye view of the ATP-binding site of CDKs in different regulatory states.
@en
type
label
An inhibitor's-eye view of the ATP-binding site of CDKs in different regulatory states.
@ast
An inhibitor's-eye view of the ATP-binding site of CDKs in different regulatory states.
@en
prefLabel
An inhibitor's-eye view of the ATP-binding site of CDKs in different regulatory states.
@ast
An inhibitor's-eye view of the ATP-binding site of CDKs in different regulatory states.
@en
P2860
P50
P356
P1433
P1476
An inhibitor's-eye view of the ATP-binding site of CDKs in different regulatory states
@en
P2093
Alison J Hole
P2860
P304
P356
10.1021/CB500135F
P577
2014-04-10T00:00:00Z